Results 101 to 110 of about 11,443 (200)
Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection. [PDF]
, 2016 Ebolaviruses pose significant public health problems due to their high lethality, unpredictable emergence, and localization to the poorest areas of the world.
A Groseth +52 more
core +2 more sources
Ebola virus disease: past, present and future
Asian Pacific Journal of Tropical Biomedicine, 2015 Ebola virus disease is one of the most deadly ailments known to mankind due to its high mortality rate (up to 90%) accompanying with the disease. Ebola haemorrhagic fever (EHF) is an infectious disease of animal that can be transmitted to both human and ...
Harish Rajak +4 more
doaj +1 more source
Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39
British Journal of Pharmacology, Volume 181, Issue 22, Page 4450-4490, November 2024.Viroporins possess important potential as antiviral targets due to their critical roles during virus life cycles, spanning from virus entry to egress. Although the antiviral amantadine targets the M2 viroporin of influenza A virus, successful progression of other viroporin inhibitors into clinical use remains challenging.
Kira Devantier +4 more
wiley +1 more source
Immunological Reviews, Volume 328, Issue 1, Page 221-242, November 2024.Summary Advances in antibody technologies have resulted in the development of potent antibody‐based therapeutics with proven clinical efficacy against infectious diseases. Several monoclonal antibodies (mAbs), mainly against viruses such as SARS‐CoV‐2, HIV‐1, Ebola virus, influenza virus, and hepatitis B virus, are currently undergoing clinical testing
Julia E. Edgar, Stylianos Bournazos
wiley +1 more source
Suspected Ebolavirus Reservoir Species in Anthropogenic Landscapes
The Bulletin of the Ecological Society of America, Volume 106, Issue 2, April 2025.
Matthew LeBreton, Robert L. Cohen
wiley +1 more source
Ebolavirus: preparados ou não?
Revista Eletronica Gestão & Saúde, 2015 O atual surto de ebola tem devastado centenas de vidas, preocupando a comunidade cientifica devido à alta letalidade e difícil controle. Objetivamos observar quais os principais desafios para o controle do vírus e entender a importância de uma gestão prévia para diminuir a propagação da doença, visando precaver um possível surto.
Rachid Figueirôa Souza +4 more
openaire +1 more source
In vitro assembly of Ebola virus nucleocapsid-like complex expressed in E. coli [PDF]
, 2016 Ebola virus (EBOV) harbors an RNA genome encapsidated by nucleoprotein (NP) along with other viral proteins to form a nucleocapsid complex. Previous Cryo-eletron tomography and biochemical studies have shown the helical structure of EBOV nucleocapsid at ...
A Nanbo +33 more
core +3 more sources
Structural Basis for Differential Neutralization of Ebolaviruses
Viruses, 2012 There are five antigenically distinct ebolaviruses that cause hemorrhagic fever in humans or non-human primates (Ebola virus, Sudan virus, Reston virus, Taï Forest virus, and Bundibugyo virus).
John M. Dye +11 more
doaj +1 more source
Risks Posed by Reston, the Forgotten Ebolavirus [PDF]
, 2016 Out of the five members of the Ebolavirus family, four cause lifethreatening disease, whereas the fifth, Reston virus (RESTV), is nonpathogenic in humans. The reasons for this discrepancy remain unclear. In this review, we analyze the currently available
Arran Hamlet +5 more
core +2 more sources
Ebolavirus and evidence-based speculations.
The new microbiologica, 2016 .
Focosi, Daniele +2 more
openaire +4 more sources